ROP vs STRO
Roper Technologies, Inc. (ROP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ROP and STRO stock pages for the full models.
Not investment advice.